Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference21 articles.
1. Research CfDEa. General principles for evaluating the abuse deterrence of generic solid Oral opioid drug products. In: Services USDoHaH, Administration FaD, editors. 2016.
2. Perrino P, Colucci S, Apseloff G, Harris S. Pharmacokinetics, tolerability, and safety of intranasal Administration of Reformulated OxyContin tablets compared with original OxyContin tablets in healthy adults. Clin Drug Invest. 2013;33(6):441–9.
3. Harris SC, Perrino PJ, Smith I, Shram MJ, Colucci SV, Bartlett C, et al. Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users. J Clin Pharmacol. 2014;54(4):468–77.
4. Harris SC, Cipriano A, Colucci SV, Kapil RP, Geoffroy P, Hopyan T, et al. Intranasal abuse potential, pharmacokinetics, and safety of once-daily, single-entity, extended-release hydrocodone (HYD) in recreational opioid users. Pain Med. 2016;17(5):820–31.
5. Boyce H, Smith D, Byrn S, Saluja B, Qu W, Gurvich VJ, et al. In vitro assessment of nasal insufflation of comminuted drug products designed as abuse deterrent using the vertical diffusion cell. AAPS PharmSciTech. 2018;19(4):1744–57.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献